Ketamine Spray Effective for Suicidality, but Concerns Linger

Intranasal esketamine added to standard antidepressant therapy rapidly reduces symptoms of major depression and suicidality in patients at risk for suicide, but experts worry about the potential for abuse.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply